Relmada Therapeutics (RLMD) Files $250M Mixed Shelf

August 30, 2024 4:25 PM UTC

Relmada Therapeutics (NASDAQ: RLMD) has filed $250,000,000 mixed shelf of:

COMMON STOCK

PREFERRED STOCK

WARRANTS

SUBSCRIPTION RIGHTS

DEPOSITARY SHARES

PURCHASE CONTRACTS

UNITS




Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Equity Offerings

Related Entities

UBS, Maynard Um, Mark Zuckerberg, ARK